cysteine has been researched along with Nerve Degeneration in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (13.64) | 18.7374 |
| 1990's | 2 (9.09) | 18.2507 |
| 2000's | 12 (54.55) | 29.6817 |
| 2010's | 5 (22.73) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jackson, MJ; McArdle, A; McDonagh, B; Pollock, N; Scullion, SM; Vasilaki, A | 1 |
| Drinkut, A; Falkenburger, BH; Gerhardt, E; Krenz, A; Schulz, JB | 1 |
| Bähr, M; Garrido, M; Kügler, S; Taschenberger, G; Tereshchenko, Y; Zhevtsova, Z | 1 |
| Andersen, JK; Danielson, SR; Gibson, BW; Held, JM; Oo, M; Riley, R | 1 |
| Ahmad, A; Ahmed, ME; Ashafaq, M; El-Agnaf, OM; Islam, F; Javed, H; Khan, A; Khan, MM; Khuwaja, G; Raza, SS; Safhi, MM; Siddiqui, MS; Tabassum, R; Vaibhav, K | 1 |
| Chauhan, NB; Lahiri, DK; Ray, B | 1 |
| Liu, RM | 1 |
| Guerra, MJ; Labandeira-Garcia, JL; Muñoz, AM; Rey, P; Soto-Otero, R | 1 |
| Aoyama, K; Chan, WY; Chen, Y; Hamby, AM; Liu, J; Suh, SW; Swanson, RA | 1 |
| Koyama, M; Yagishita, A | 1 |
| LoPachin, RM | 1 |
| Ali, T; Aly, Z; Frossard, PM; Khealani, B; Saleheen, D | 1 |
| Barsoum, MJ; Bossy-Wetzel, E; Lipton, SA; Malhotra, V; Nakagomi, S; Sütterlin, C | 1 |
| Donaldson, PL; Duce, IR; Usherwood, PN | 1 |
| Fonnum, F; Grofova, I; Karlsen, RL; Malthe-Sørenssen, D | 1 |
| Hagberg, H; Lehmann, A; Orwar, O; Sandberg, M | 1 |
| Hagberg, H; Puka-Sundvall, M; Sandberg, M | 1 |
| Dietrich, P; Mason, TB; Mendelsohn, M; Role, LW; Talmage, DA; Wolpowitz, D | 1 |
| Hastings, TG; Lewis, DA; Rabinovic, AD | 1 |
| Ishida, R; Mizusawa, H; Murata, Y; Saitoh, Y; Shibuya, H; Zhang, L | 1 |
| Amarnath, V; Montine, TJ; Olson, SJ; Ou, JJ; Sidell, KR; Zhang, Y | 1 |
| Ho, OL; Olney, JW; Rhee, V; Schainker, B | 1 |
2 review(s) available for cysteine and Nerve Degeneration
| Article | Year |
|---|---|
The "aged garlic extract:" (AGE) and one of its active ingredients S-allyl-L-cysteine (SAC) as potential preventive and therapeutic agents for Alzheimer's disease (AD).
Topics: Alzheimer Disease; Cysteine; Garlic; Humans; Inflammation; Nerve Degeneration; Plant Extracts | 2011 |
Acrylamide neurotoxicity: neurological, morhological and molecular endpoints in animal models.
Topics: Acrylamide; Acrylamides; Animals; Cell Membrane; Chemical Industry; Cysteine; Disease Models, Animal; Electrophysiology; Humans; Muscle, Skeletal; Nerve Degeneration; Nervous System Diseases; Neurons; Neurotoxicity Syndromes; Neurotoxins; Rats; Temperature; Time Factors | 2005 |
1 trial(s) available for cysteine and Nerve Degeneration
| Article | Year |
|---|---|
Differentiating between progressive supranuclear palsy and corticobasal degeneration by brain perfusion SPET.
Topics: Aged; Aged, 80 and over; Basal Ganglia; Cerebral Cortex; Cerebrovascular Circulation; Cysteine; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Nerve Degeneration; Organotechnetium Compounds; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon | 2001 |
19 other study(ies) available for cysteine and Nerve Degeneration
| Article | Year |
|---|---|
Ageing-induced changes in the redox status of peripheral motor nerves imply an effect on redox signalling rather than oxidative damage.
Topics: Aging; Animals; Cysteine; Electron Spin Resonance Spectroscopy; Humans; Mice; Muscle Fibers, Skeletal; Muscle, Skeletal; Nerve Degeneration; Neuromuscular Junction; Oxidation-Reduction; Oxidative Stress; Peripheral Nerves; Peroxiredoxin VI; Proteomics; Sciatic Nerve; Superoxides | 2016 |
Aggregate formation and toxicity by wild-type and R621C synphilin-1 in the nigrostriatal system of mice using adenoviral vectors.
Topics: Adenoviridae; Animals; Arginine; Benzothiazoles; Carrier Proteins; Corpus Striatum; Cysteine; Gene Expression; Genetic Vectors; Green Fluorescent Proteins; Intracellular Signaling Peptides and Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Nerve Degeneration; Nerve Tissue Proteins; Substantia Nigra; Thiazoles; Tyrosine 3-Monooxygenase | 2009 |
Glutathione depletion and overproduction both initiate degeneration of nigral dopaminergic neurons.
Topics: alpha-Synuclein; Analysis of Variance; Animals; Apomorphine; Catalytic Domain; Cell Survival; Cysteine; Disease Models, Animal; Dopamine; Dopamine Agonists; Female; Gene Expression Regulation; Gliosis; Glutathione; Glutathione Reductase; Green Fluorescent Proteins; Movement; Nerve Degeneration; Rats; Rats, Wistar; RNA, Small Interfering; Sensation Disorders; Stereotyped Behavior; Substantia Nigra; Time Factors; Transduction, Genetic; Tyrosine 3-Monooxygenase; Vesicular Monoamine Transport Proteins | 2011 |
Quantitative mapping of reversible mitochondrial Complex I cysteine oxidation in a Parkinson disease mouse model.
Topics: Alkylation; Animals; Crystallography; Cysteine; Disease Models, Animal; Electron Transport Complex I; Glutathione; Immunoassay; Male; Mass Spectrometry; Mice; Mice, Inbred C57BL; Mitochondria; Nerve Degeneration; Oxidation-Reduction; Parkinson Disease; Protein Structure, Tertiary | 2011 |
S-allyl cysteine attenuates oxidative stress associated cognitive impairment and neurodegeneration in mouse model of streptozotocin-induced experimental dementia of Alzheimer's type.
Topics: Alzheimer Disease; Animals; Antioxidants; Apoptosis; Cysteine; Disease Models, Animal; Immunohistochemistry; Injections, Intraventricular; Maze Learning; Mice; Nerve Degeneration; Neurotoxins; Oxidative Stress; Streptozocin | 2011 |
Down-regulation of gamma-glutamylcysteine synthetase regulatory subunit gene expression in rat brain tissue during aging.
Topics: Aging; Animals; Brain; Cysteine; Dipeptides; Down-Regulation; gamma-Glutamyltransferase; Gene Expression Regulation, Enzymologic; Glutathione; Glutathione Disulfide; Glutathione Reductase; Glutathione Synthase; Male; Nerve Degeneration; Oxidative Stress; Rats; Rats, Inbred F344; Regulatory Sequences, Nucleic Acid | 2002 |
Systemic administration of N-acetylcysteine protects dopaminergic neurons against 6-hydroxydopamine-induced degeneration.
Topics: Acetylcysteine; Animals; Antigens, CD; Antigens, Neoplasm; Antigens, Surface; Ascorbic Acid; Avian Proteins; Basigin; Blood Proteins; Cell Count; Corpus Striatum; Cysteine; Dopamine; Drug Administration Routes; Female; Fluoresceins; Fluorescent Dyes; Free Radical Scavengers; Glial Fibrillary Acidic Protein; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Hydroxydopamines; Immunohistochemistry; Membrane Glycoproteins; Nerve Degeneration; Neurons; Organic Chemicals; Phosphopyruvate Hydratase; Rats; Rats, Sprague-Dawley; Tyrosine 3-Monooxygenase | 2004 |
Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse.
Topics: Acetylcysteine; Aging; Animals; Behavior, Animal; Bicuculline; Blotting, Western; Brain; Cysteine; Excitatory Amino Acid Transporter 3; GABA Antagonists; Genotype; Glutathione; Immunohistochemistry; Mice; Mice, Knockout; Nerve Degeneration; Neurons; Oxidants; Oxidative Stress | 2006 |
Pantothenate kinase-associated neurodegeneration with increased lentiform nuclei cerebral blood flow.
Topics: Brain; Cerebrovascular Circulation; Child; Corpus Striatum; Cysteine; Humans; Magnetic Resonance Imaging; Male; Mutation; Nerve Degeneration; Organotechnetium Compounds; Pantothenate Kinase-Associated Neurodegeneration; Phosphotransferases (Alcohol Group Acceptor); Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2006 |
Novel mutation in the PANK2 gene leads to pantothenate kinase-associated neurodegeneration in a Pakistani family.
Topics: Adolescent; Amino Acid Substitution; Basal Ganglia; Child; Cysteine; DNA Mutational Analysis; Genes, Recessive; Homozygote; Humans; Iron; Male; Mutation; Nerve Degeneration; Pakistan; Phosphotransferases (Alcohol Group Acceptor); Tyrosine | 2007 |
A Golgi fragmentation pathway in neurodegeneration.
Topics: Analysis of Variance; Animals; Apoptosis; Cells, Cultured; Cerebral Cortex; Cysteine; Dose-Response Relationship, Drug; Embryo, Mammalian; Excitatory Amino Acid Agonists; Golgi Apparatus; Luminescent Proteins; Mitochondria; N-Methylaspartate; Nerve Degeneration; Neurons; Nitric Oxide Donors; Rats; S-Nitrosothiols; Signal Transduction; Time Factors; Transfection; Tubulin | 2008 |
Investigations into the mechanism of excitant amino acid cytotoxicity using a well-characterized glutamatergic system.
Topics: Animals; Aspartic Acid; Concanavalin A; Cysteine; Dose-Response Relationship, Drug; Glutamates; Glutamic Acid; Grasshoppers; Kainic Acid; Nerve Degeneration; Neuromuscular Junction; Neurotransmitter Agents; Oxadiazoles; Quisqualic Acid; Receptors, Cell Surface; Receptors, Glutamate; Synaptic Transmission | 1983 |
Morphological changes in rat brain induced by L-cysteine injection in newborn animals.
Topics: Amygdala; Animals; Animals, Newborn; Atrophy; Brain; Cerebral Cortex; Cysteine; Hippocampus; Mesencephalon; Nerve Degeneration; Neural Pathways; Rats; Thalamic Nuclei | 1981 |
Cysteine sulphinate and cysteate: mediators of cysteine toxicity in the neonatal rat brain?
Topics: Amino Acids; Animals; Animals, Newborn; Brain; Cerebral Cortex; Cysteic Acid; Cysteine; Dizocilpine Maleate; Female; Male; Nerve Degeneration; Neurons; Neurotoxins; Neurotransmitter Agents; Organ Specificity; Quinoxalines; Rats; Rats, Sprague-Dawley | 1993 |
Brain injury after neonatal hypoxia-ischemia in rats: a role of cysteine?
Topics: Animals; Animals, Newborn; Brain Chemistry; Brain Ischemia; Cysteine; Female; Hypoxia, Brain; Male; Microdialysis; Nerve Degeneration; Rats; Rats, Wistar; Sulfur | 1998 |
Cysteine-rich domain isoforms of the neuregulin-1 gene are required for maintenance of peripheral synapses.
Topics: Animals; Cell Communication; Cell Survival; Cysteine; Female; Gene Expression Regulation, Developmental; Isomerism; Lung; Male; Mice; Mice, Knockout; Motor Neurons; Muscle, Skeletal; Mutagenesis; Nerve Degeneration; Neuregulin-1; Neuroglia; Neurons, Afferent; Phrenic Nerve; Recombinant Proteins; Respiratory Mechanics; Rhombencephalon; Schwann Cells; Signal Transduction; Synapses; Transcription, Genetic | 2000 |
Role of oxidative changes in the degeneration of dopamine terminals after injection of neurotoxic levels of dopamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cysteine; Dopamine; Down-Regulation; Extracellular Space; Glutathione; Male; Neostriatum; Nerve Degeneration; Oxidative Stress; Parkinson Disease; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Tyrosine 3-Monooxygenase | 2000 |
Cysteine and mercapturate conjugates of oxidized dopamine are in human striatum but only the cysteine conjugate impedes dopamine trafficking in vitro and in vivo.
Topics: Acetylcysteine; Aged; Aged, 80 and over; Animals; Brain; Cells, Cultured; Corpus Striatum; Cysteine; Dopamine; Esters; Female; Fetus; Humans; In Vitro Techniques; Male; Mesencephalon; Microdialysis; Nerve Degeneration; Oxidation-Reduction; Parkinson Disease; Rats; Rats, Sprague-Dawley; Synaptosomes | 2001 |
Cysteine-induced brain damage in infant and fetal rodents.
Topics: Animals; Animals, Newborn; Brain; Brain Damage, Chronic; Cysteine; Female; Fetal Diseases; Maternal-Fetal Exchange; Mice; Nerve Degeneration; Pregnancy; Rats | 1972 |